Gibbons Welcomes New Director to New York Office


October 19, 2016

Gibbons P.C. is pleased to announce the arrival of Tryn T. Stimart, who is joining the firm’s New York office as a Director in the Intellectual Property Department.

Most recently, Mr. Stimart was a partner at Womble Carlyle in Tysons Corner, Virginia. Well-armed with undergraduate and graduate scientific degrees in biochemistry, chemistry, and genetics/cell biology, Mr. Stimart focuses his practice on intellectual property litigation in district courts and the USPTO in the fields of pharmaceuticals, biopharmaceuticals, biotechnology, medical diagnostics, and biofuels, as well as computer software and video compression technology. Mr. Stimart also regularly advises clients on intellectual property pre-litigation strategies, inter partes reviews, due diligence and opinion work, licensing, mergers and acquisitions, and strategic intellectual property counseling.

Mr. Stimart earned his J.D., cum laude, from American University, Washington College of Law, his M.S. from Old Dominion University with a research thesis on HIV-1 reverse transcriptase, and his dual B.S. in Biochemistry and Genetics/Cell Biology from the University of Minnesota. He is admitted to practice in the District of Colombia; the Commonwealth of Virginia; the state of Maryland; the U.S. District Courts for the Eastern District of Virginia, District of Columbia, and District of Maryland; the U.S. Court of Appeals for the Federal Circuit; the U.S. Court of Appeals for Veterans Claims; and the U.S. Court of Federal Claim. Mr. Stimart is also a former United States Naval Officer and served on active duty and in the reserves.

Mr. Stimart also brings unique experience and a distinctly relevant perspective that will greatly benefit the firm’s clients. Prior to becoming an attorney, he was an Advisor with the Advanced Technology Program at the National Institute of Standards and Technology (NIST), where he was a program manager and reviewed complex technical proposals on cutting-edge technology that involved any use of humans or animals in research. He represented the United States Department of Commerce on a federal level as part of the Human Research Protections Program and earned a Bronze Medal for superior performance concerning the use of human embryonic stem cells.

“Tryn’s extensive scientific background, in both his academic and professional careers, is exactly the kind of relevant industry insight our attorneys bring to our clients’ matters,” says Patrick C. Dunican Jr., Chairman and Managing Director of Gibbons. “He enhances and expands the scope of experience our attorneys can rely on to address client issues and provide effective solutions.”